Our favorite Carslbad-based life sciences company, Invitrogen, has just introduced a new bench-top instrument called the Countess automated cell counter, according to a story in Pharmaceutical Business Review .
According to the company, the Countess instrument: counts live and dead cells, calculates percent viability, measures average cell size, calculates dilutions for downstream applications and uses just 10 microliters of sample.
As usual, we have no idea what they’re talking about, but if it’s good for their stock price then it’s fine by us.
[Link: Pharmaceutical Business Review]
RSS Feed-Posts
{ 0 comments… add one now }